NCT06422949View on ClinicalTrials.gov

Efficacy and Safety of HILOTERM® Device for the Prevention of Peripheral Neuropathy

NANot yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 15, 2024

Primary Completion Date

August 15, 2027

Study Completion Date

August 15, 2027

Conditions
Breast CancerNeuropathy;Peripheral
Interventions
DEVICE

Hilotherm® Cooling treatment

Patient will receive cooling treatment with Hilotherm® at hands and feet level from half an hour before taxol treatment start until half an hour after treatment end

Trial Locations (1)

20141

European Institute of Oncology, Milan

All Listed Sponsors
lead

European Institute of Oncology

OTHER

NCT06422949 - Efficacy and Safety of HILOTERM® Device for the Prevention of Peripheral Neuropathy | Biotech Hunter | Biotech Hunter